Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Azurocidin/HBP Mouse mAb, PerCP-Cy5.5 conjugated

Azurocidin/HBP Mouse mAb, PerCP-Cy5.5 conjugated is a PerCP/Cy5.5 conjugated antibody targeting AZU1. This antibody is suitable for IF. It exhibits reactivity with Human samples.

Product Specifications

Product Name Alternative

Azu 1; Azu1; CAP37; CAP7_HUMAN; cationic antimicrobial protein 37; Cationic antimicrobial protein CAP37; HBP; Heparin binding protein; Heparin-binding protein; HUMAZUR.

Reactivity

Human

Immunogen

Recombinant Human Azurocidin Protein (20-250/251aa)

Target

AZU1

Clonality

Monoclonal

Clone

B7H3

Conjugation

PerCP/Cy5.5

Purification

Affinity purified by Protein A

Dilution

IF=1:100-500

Storage Conditions

Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Notes

For research use only.

Tested Applications

IF

Host or Source

Mouse

Preservative

0.01M PBS (pH7.4) .

Isotype

IgG1

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Muffle Box Furnace BFMF-1300-20
BFMF-1300-20 1 Unit

Muffle Box Furnace BFMF-1300-20

Sign In for Pricing
View Details
PCDH19 Human Gene Knockout Kit (CRISPR)
KN423675 1 Kit

PCDH19 Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Immobilized Calystega sepiem Lectin (Hedge Bindweed Rhizomes) -Calsepa
A-8011-1 1 mL

Immobilized Calystega sepiem Lectin (Hedge Bindweed Rhizomes) -Calsepa

Sign In for Pricing
View Details
CO 1686
TRC-C633000-50MG 50 mg

CO 1686

Sign In for Pricing
View Details
PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus) (PAPPA/2718), CF640R conjugate, 0.1mg/mL
BNC402718-500 1x 500 µL

PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus) (PAPPA/2718), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Human CHD8 activation kit by CRISPRa
GA111679 1 Kit

Human CHD8 activation kit by CRISPRa

Sign In for Pricing
View Details